Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edmondo Falleti

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Annals of Hepatology|February 5, 2016
Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplantSara Bignulin, Edmondo Falleti, Sara Cmet, et al.
Oncology|November 27, 2009
Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver diseaseEdmondo Falleti, Carlo Fabris, Pierluigi Toniutto, et al.
Journal of Hepatology|June 20, 2024
Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtidePierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 6, 2022
Immunogenicity and safety of a third dose of anti-SARS-CoV-2 BNT16b2 vaccine in liver transplant recipientsPierluigi Toniutto, Annarosa Cussigh, Sara Cmet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 24, 2010
Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis CDavide Bitetto, Carlo Fabris, Ezio Fornasiere, et al.
Plos One|November 19, 2013
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis CEdmondo Falleti, Sara Cmet, Carlo Fabris, et al.
Journal of Clinical Immunology|June 8, 2011
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotypeEdmondo Falleti, Davide Bitetto, Carlo Fabris, et al.
Inflammation|January 21, 2010
Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver diseaseElisabetta Fontanini, Annarosa Cussigh, Carlo Fabris, et al.
Transplantation|April 13, 2012
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor usedDavide Bitetto, Carlo Fabris, Edmondo Falleti, et al.
Journal of Hepatology|March 14, 2022
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipientsPierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Annals of Hepatology|February 5, 2016
Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplantSara Bignulin, Edmondo Falleti, Sara Cmet, et al.
Oncology|November 27, 2009
Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver diseaseEdmondo Falleti, Carlo Fabris, Pierluigi Toniutto, et al.
Journal of Hepatology|June 20, 2024
Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtidePierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 6, 2022
Immunogenicity and safety of a third dose of anti-SARS-CoV-2 BNT16b2 vaccine in liver transplant recipientsPierluigi Toniutto, Annarosa Cussigh, Sara Cmet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 24, 2010
Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis CDavide Bitetto, Carlo Fabris, Ezio Fornasiere, et al.
Plos One|November 19, 2013
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis CEdmondo Falleti, Sara Cmet, Carlo Fabris, et al.
Journal of Clinical Immunology|June 8, 2011
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotypeEdmondo Falleti, Davide Bitetto, Carlo Fabris, et al.
Inflammation|January 21, 2010
Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver diseaseElisabetta Fontanini, Annarosa Cussigh, Carlo Fabris, et al.
Transplantation|April 13, 2012
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor usedDavide Bitetto, Carlo Fabris, Edmondo Falleti, et al.
Journal of Hepatology|March 14, 2022
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipientsPierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Pageof 6